In this review, we first examine the contextual background of structure-pha
rmacokinetic relationships. Some concepts in drug disposition are briefly r
ecalled, and inherent difficulties in structure-pharmacokinetic relationshi
ps are outlined. Lipophilicity is then investigated in the light of the int
ermolecular and intramolecular interactions it encodes. In the main body of
the review, a number of pharmacokinetic processes are examined for their r
elations with lipophilicity. These processes are taken in a logical sequenc
e of permeation, absorption (intestine, skin, cornea, brain), plasma protei
n binding, tissue distribution, volume of distribution and renal clearance.
Relations between metabolism and lipophilicity are more complex, since bio
transformation involves both low-energy (enzyme binding) and high-energy (c
atalysis) processes. Only the former may be related to lipophilicity. The c
onclusion argues against faulty statistics and over-interpretation.